‘We’ll See Some Pretty Big Changes’: How One Top Biotech Investor Eyes Healthcare In A Post-Coronavirus World

The COVID-19 pandemic is reshaping industries across the spectrum, and healthcare is being impacted most of all. As hospitals, doctors, pharmas and biotechs pivot to fight the deadly disease, venture capitalist Kirstina Burow sees the industry emerging stronger as it is forced to innovate.